Natasha Garg, DO, discusses the utility of novel imaging techniques in patients with nonmetastatic castration-resistant prostate cancer.
Natasha Garg, DO
Advertisement
Articles by Natasha Garg, DO
Natasha Garg, DO, discusses the emergence of antiandrogen agents in the nonmetastatic castration-resistant prostate cancer treatment paradigm.
Natasha Garg, DO, discusses selecting between antiandrogen agents in nonmetastatic castration-resistant prostate cancer.
Advertisement
Latest Updated Articles
Dr. Garg on the Emergence of Antiandrogen Agents in nmCRPCPublished: August 25th 2021 | Updated:
Dr. Garg on the Need for Novel Imaging Techniques in nmCRPCPublished: September 1st 2021 | Updated:
Dr. Garg on Selecting Between Antiandrogen Agents in Nonmetastatic CRPCPublished: May 21st 2021 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
2
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
3
FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma
4
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
5